Available Until 12/13/2022

Clinical Sessions for Recertification: Ambulatory Care Pharmacy (Cert # L219360)

ACPE Numbers: Various – see listing below
Pre-Sale Date: N/A
Content Release Date: 12/15/2021
Expiration Date: 12/13/2022
Activity Type: Application-based
CE Credits: 6.0 (BPS and ACPE) contact hours
Activity Fee: $150 (ASHP member); $250 (non-member)

Activity Overview

The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in ambulatory care pharmacy. 

The Ambulatory Care Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 6.0 contact hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP and ACCP professional development program for BCACP recertification approved by the BPS.  For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below).

The American Society of Health-System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Ambulatory Care
  • Ageism
  • Direct oral anticoagulant dilemmas
  • CKD
  • Opioid use disorder

Board certified pharmacists are eligible to receive up to 6.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

Recertification credit is earned in the calendar year in which you pass the recertification assessment. 

Learning Activity

ACPE Number

Contact Hours (ACPE & BPS)

Recertification Assessment

Road to Recovery: Caring for Persons Living with Opioid Use Disorder in an Ambulatory Care Setting (BCACP)

0217-9999-21-154-H08-P

2.00

77%

Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships (BCACP, BCGP)

0204-9999-21-237-H04-P

1.00

75%

Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease (BCACP, BCGP)

0204-9999-21-321-H01-P 1.50

73%

Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care (BCACP, BCGP)

0217-9999-21-155-H01-P

1.50

71%

Road to Recovery: Caring for Persons Living with Opioid Use Disorder in an Ambulatory Care Setting
ACPE Number: 0217-9999-21-154-H08-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Summarize the epidemiology of opioid use disorder.
  • Describe harm reduction strategies for patients living with opioid use disorder.
  • Evaluate various opioid use disorder treatment options and the benefits or risks associated with each.
  • Identify barriers and successes for implementing opioid use disorder treatment into primary care.
  • Develop a harm reduction and treatment plan for persons living with opioid use disorder.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit. 

Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships
ACPE Number: 0204-9999-21-237-H04-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess personal communication techniques with older adults for unintended ageist tendencies.
  • Recommend practices to combat areas of known ageism in institutional and ambulatory healthcare settings.
  • Develop a personalized action plan for recognizing personal and systematic ageist tendencies in healthcare.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease
ACPE Number: 0204-9999-21-321-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess stroke risk and the net clinical benefit of anticoagulation in the oldest old (i.e., patients age ≥80 years) with atrial fibrillation.
  • Assess stroke risk and the net clinical benefit of anticoagulation in patients with end-stage renal disease and concomitant atrial fibrillation.
  • Recommend a direct oral anticoagulant regimen for stroke prevention for the oldest old with atrial fibrillation based on guideline recommendations and primary literature.
  • Recommend a direct oral anticoagulant regimen for stroke prevention for a patient with end-stage renal disease and atrial fibrillation based on guideline recommendations and primary literature.
  • Identify common medication errors involving direct oral anticoagulants for the oldest old or patients with end-stage renal disease.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care
ACPE Number: 0217-9999-21-155-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess a medication regimen in a patient with complex comorbidities to select appropriate recommendations for renal adjustment.
  • Design a treatment plan for cardiovascular disease management in a patient with chronic kidney disease.
  • Apply key factors of patient safety and efficacy to consider when determining a treatment plan in a patient with chronic kidney disease and osteoporosis.
  • Incorporate ways a clinical pharmacist can play a role in quality care metrics and chronic kidney disease management in everyday practice.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Faculty bios

Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
Professor & Division Head – Geriatrics
Texas Tech University HSC School of Pharmacy
Dallas, Texas 

Nicole M. Hahn, Pharm.D., BCACP*
Clinical Pharmacy Specialist - Neurology
Kaiser Permanente
Denver, Colorado 

Michelle L. Hilaire, Pharm.D., FCCP, BCPS, BCACP, CDE*
Clinical Professor
University of Wyoming
Laramie, Wyoming 

Adam B. Jackson, Pharm.D., BCACP*
Clinical Pharmacy Specialist
Pharmacy Department
Kaiser Permanente Colorado
Denver, Colorado 

Cherry Jackson, Pharm.D., FASHP, FCCP, BCPP
Professor of Pharmacy, Auburn University
Clinical Professor Psychiatry and Behavioral
Neurobiology
University of Alabama Birmingham
Birmingham, Alabama 

Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP*
ssociate Professor of Pharmacy Practice
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania 

Jamie L. McConaha, Pharm.D., BCACP*
Associate Professor of Pharmacy Practice
Mylan School of Pharmacy Clinical, Social, and Administrative Sciences
Duquesne University
Pittsburgh, Pennsylvania 

Zachary R. Noel, Pharm.D., BCCP, BCPS
Assistant Professor, Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland 

Maria Pruchnicki, Pharm.D., FCCP, BCPS, BCACP, CLS
Associate Professor - Clinical
The Ohio State University
Columbus, Ohio 

Krystal Riccio, Pharm.D., BCACP, CDCES
Associate Professor of Pharmacy Practice
Research Center on Substance Abuse and Depression
Roseman University of the Health Sciences
Henderson, Nevada 

Tiffany Shin, Pharm.D., BCACP
Clinical Assistant Professor
University of Kansas
Wichita, Kansas 

Barbara J. Zarowitz, Pharm.D., BCPS, BCGP, FASCP
Senior Advisor, Peter Lamy Center on Drug Therapy and Aging
Affiliate Professor, University of Maryland School of Pharmacy
Baltimore, Maryland 

*Content Matter Experts

Holly L. Byrnes, Pharm D., BCPS
Dana Carroll, Pharm.D., BCPS, CDE, BCGP
Susan R. Dombrowski, M.S., R.Ph.
Michelle Hilaire  Pharm.D., BCACP, BCPS, CDE, FCCP
Kristi Hofer, Pharm.D.
Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
Maria Shin, Pharm.D., BCGP, BCPS

Michael Andrews, Pharm.D., BCPS, BCACP
Ramadas Balasubramanian, Pharm.D., Ph.D., BCGP, BCACP, FASCP
Carol Botelho, Pharm.D., BCACP, BCGP
James Bottoms, BCGP, CPH
Tina Caliendo, Pharm.D., BCGP, BCACP
Christine Chou, Pharm.D., BCPS, BCGP
Emily Christenberry, Pharm.D., BCPS, BCGP
Ariane Conrad, Pharm.D., BCACP, CDCES, FISMP
Stacey Dean, Pharm.D., MSHA
Andrea  Donaldson, Pharm.D., BCPS, BCGP
Valerie Emming-Eschbacher, Pharm.D., BCACP
Barbara Fiano, BCGP
Jennifer Fix, B.S., Pharm.D., MBA
Kevin Fuschetto, Pharm.D., BCACP, BC-ADM
Megan Grischeau, Pharm.D., BCACP
Mark Hall, Pharm.D., BCACP
Rhenda Harris , Pharm.D., MBA, BCACP
Debrina Johnson, Pharm.D., BCGP, BCACP
Rebecca Khaimova, Pharm.D., BCACP
Karen Kier, BSPh, PhD, BCPS, BCACP
Laura Langemak, Pharm.D., BCACP
Nancy Laux, Pharm.D., BCPS, BCGP
Brian Leonard, Pharm.D., BCACP, BCGP
Jennifer Lis, Pharm.D., BCACP
Kristine Lopez, Pharm.D., BCGP
Matthew Maddox, Pharm.D., BCACP, BCGP, CPH
Kristen Miezianko, Pharm.D.
Tera Moore, Pharm.D., BCACP
Hilda Ng , MSc, BCGP
Alyssa Norwood, BSPharm, Pharm.D., R.Ph., BCGP
Sabrina Phillips, Pharm.D., BCACP, BCGP
Stephanie Planisek, Pharm.D., M.S., BCGP, BCMTMS
Melanie Proffitt, Pharm.D., BCACP, MHA
Muhammad Qudoos, Pharm.D., BCGP
Jocelyn Reynoso, Pharm.D., BCPS, BCGP
Krystal Riccio, Pharm.D., BCACP, CDCES
Polly Robinson, Pharm.D., BCGP, BCACP, FASCP
Lindsay Sampson, Pharm.D., BCPS, BCGP
Garcia Simon-Clarke, M.S., Pharm.D, BCNP, BCGP, BCPS
Harleen Singh, Pharm.D., BCPS, BCACP
Jeffrey Tingen, Pharm.D., MBA, BCPS, BCACP, CDCES
Nicholas Townsend, Pharm.D., BCACP
Michele  Walker, Pharm.D., BCGP
Emily Walsh, Pharm.D., BCACP
Christine Wu, Pharm.D., BCPS, BCGP
Jessica Yang, Pharm.D., BCACP, BCGP

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Krystal Riccio has taken part in the following transactions that may be considered a potential conflict of interest:
    • Speakers Bureau for AbbVie
    • Grant Reviewer for SAMHSA 

All other planners, presenters, reviewers, ACCP and ASHP staff and others with an opportunity to control content report no financial relationships relevant to this activity.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP and ACCP.